Total Payments
$66,159
2024 Payments
$61,418
Companies
31
Transactions
231
Medicare Patients
4,229
Medicare Billing
$606,936
Payment Breakdown by Category
Consulting$61,377 (92.8%)
Food & Beverage$4,645 (7.0%)
Education$137.43 (0.2%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $61,377 | 3 | 92.8% |
| Food and Beverage | $4,645 | 223 | 7.0% |
| Education | $137.43 | 5 | 0.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $60,416 | 16 | $0 (2024) |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | $1,240 | 3 | $0 (2023) |
| Otsuka America Pharmaceutical, Inc. | $634.14 | 33 | $0 (2024) |
| Amgen Inc. | $392.03 | 20 | $0 (2024) |
| Horizon Therapeutics plc | $380.18 | 22 | $0 (2023) |
| Relypsa, Inc. | $367.77 | 19 | $0 (2020) |
| NXSTAGE MEDICAL, INC. | $322.32 | 3 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $301.29 | 14 | $0 (2024) |
| Travere Therapeutics, Inc. | $262.04 | 9 | $0 (2024) |
| OPKO Pharmaceuticals, LLC | $223.59 | 12 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $61,418 | 56 | AstraZeneca Pharmaceuticals LP ($60,291) |
| 2023 | $1,850 | 31 | Otsuka Pharmaceutical Development & Commercialization, Inc. ($1,221) |
| 2022 | $791.93 | 37 | Amgen Inc. ($129.69) |
| 2021 | $264.87 | 17 | Horizon Therapeutics plc ($114.90) |
| 2020 | $212.41 | 12 | Horizon Therapeutics plc ($60.95) |
| 2019 | $553.53 | 20 | BARD PERIPHERAL VASCULAR, INC. ($121.46) |
| 2018 | $493.26 | 26 | Otsuka America Pharmaceutical, Inc. ($164.07) |
| 2017 | $575.20 | 32 | Relypsa, Inc. ($178.40) |
All Payment Transactions
231 individual payment records from CMS Open Payments — Page 1 of 10
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/02/2024 | Novartis Pharmaceuticals Corporation | Fabhalta (Drug) | Food and Beverage | In-kind items and services | $27.34 | General |
| Category: Immunology | ||||||
| 12/02/2024 | Novartis Pharmaceuticals Corporation | Fabhalta (Drug) | Food and Beverage | In-kind items and services | $27.18 | General |
| Category: Immunology | ||||||
| 11/20/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $20.54 | General |
| Category: DIABETES | ||||||
| 11/14/2024 | Novartis Pharmaceuticals Corporation | Fabhalta (Drug) | Food and Beverage | In-kind items and services | $19.59 | General |
| Category: Immunology | ||||||
| 11/09/2024 | Amgen Inc. | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $23.47 | General |
| Category: Inflammation/Rare Disease | ||||||
| 11/06/2024 | CALLIDITAS THERAPEUTICS US INC. | TARPEYO (Drug) | Food and Beverage | In-kind items and services | $23.94 | General |
| Category: Nephrology | ||||||
| 10/30/2024 | AKEBIA THERAPEUTICS INC | Vafseo (Drug) | Education | In-kind items and services | $24.61 | General |
| Category: Nephrology | ||||||
| 10/30/2024 | AKEBIA THERAPEUTICS INC | Vafseo (Drug) | Food and Beverage | In-kind items and services | $3.10 | General |
| Category: Nephrology | ||||||
| 10/29/2024 | Otsuka America Pharmaceutical, Inc. | JYNARQUE (Drug) | Food and Beverage | In-kind items and services | $10.76 | General |
| Category: NEPHROLOGY | ||||||
| 10/28/2024 | Otsuka America Pharmaceutical, Inc. | JYNARQUE (Drug) | Food and Beverage | In-kind items and services | $1.24 | General |
| Category: NEPHROLOGY | ||||||
| 10/28/2024 | Otsuka America Pharmaceutical, Inc. | JYNARQUE (Drug) | Food and Beverage | In-kind items and services | $0.70 | General |
| Category: NEPHROLOGY | ||||||
| 10/23/2024 | Alexion Pharmaceuticals, Inc. | ULTOMIRIS (Biological) | Food and Beverage | In-kind items and services | $22.53 | General |
| Category: Rare Disease | ||||||
| 09/18/2024 | Novartis Pharmaceuticals Corporation | Fabhalta (Drug) | Food and Beverage | In-kind items and services | $7.20 | General |
| Category: Immunology | ||||||
| 09/17/2024 | Travere Therapeutics, Inc. | — | Food and Beverage | In-kind items and services | $26.72 | General |
| 09/12/2024 | AKEBIA THERAPEUTICS INC | Auryxia (Drug), Vafseo | Food and Beverage | In-kind items and services | $29.04 | General |
| Category: Nephrology | ||||||
| 09/09/2024 | Novartis Pharmaceuticals Corporation | Fabhalta (Drug) | Food and Beverage | In-kind items and services | $31.50 | General |
| Category: Immunology | ||||||
| 08/27/2024 | Amgen Inc. | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $32.32 | General |
| Category: Inflammation/Rare Disease | ||||||
| 08/27/2024 | Amgen Inc. | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $26.24 | General |
| Category: Inflammation/Rare Disease | ||||||
| 08/23/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Consulting Fee | Cash or cash equivalent | $40,118.00 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 08/23/2024 | Travere Therapeutics, Inc. | — | Food and Beverage | In-kind items and services | $14.18 | General |
| 08/21/2024 | Otsuka America Pharmaceutical, Inc. | JYNARQUE (Drug) | Food and Beverage | In-kind items and services | $11.65 | General |
| Category: NEPHROLOGY | ||||||
| 08/21/2024 | Otsuka America Pharmaceutical, Inc. | JYNARQUE (Drug) | Food and Beverage | In-kind items and services | $5.47 | General |
| Category: NEPHROLOGY | ||||||
| 07/17/2024 | AKEBIA THERAPEUTICS INC | Auryxia (Drug), Vafseo | Food and Beverage | In-kind items and services | $28.09 | General |
| Category: Nephrology | ||||||
| 07/16/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Consulting Fee | Cash or cash equivalent | $20,059.00 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 06/25/2024 | AstraZeneca Pharmaceuticals LP | LOKELMA (Drug) | Food and Beverage | In-kind items and services | $16.12 | General |
| Category: Cardiovascular and Metabolism | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 13 | 878 | 1,433 | $337,335 | $128,954 |
| 2022 | 15 | 1,032 | 2,109 | $387,763 | $150,129 |
| 2021 | 18 | 1,003 | 2,384 | $389,352 | $158,365 |
| 2020 | 20 | 1,316 | 2,811 | $453,108 | $169,488 |
Total Patients
4,229
Total Services
8,737
Medicare Billing
$606,936
Procedure Codes
66
All Medicare Procedures & Services
66 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 90960 | Dialysis services, 4 or more physician visits per month (20 years or older) | Office | 2023 | 21 | 116 | $76,676 | $31,603 | 41.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 246 | 354 | $62,658 | $21,961 | 35.0% |
| 90966 | Home dialysis services per month (20 years or older) | Office | 2023 | 25 | 92 | $39,468 | $20,590 | 52.2% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 145 | 267 | $36,312 | $15,980 | 44.0% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 83 | 85 | $25,075 | $8,235 | 32.8% |
| 90935 | Hemodialysis procedure with physician evaluation | Facility | 2023 | 82 | 146 | $22,192 | $7,827 | 35.3% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 38 | 54 | $10,260 | $4,847 | 47.2% |
| 90961 | Dialysis services, 2-3 physician visits per month (20 years or older) | Office | 2023 | 15 | 21 | $9,009 | $4,652 | 51.6% |
| 90945 | Dialysis procedure including 1 evaluation | Facility | 2023 | 32 | 72 | $33,048 | $4,622 | 14.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 31 | 31 | $7,564 | $3,476 | 46.0% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 25 | 25 | $9,300 | $3,282 | 35.3% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 124 | 157 | $2,198 | $1,303 | 59.3% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 11 | 13 | $3,575 | $575.72 | 16.1% |
| 90960 | Dialysis services, 4 or more physician visits per month (20 years or older) | Office | 2022 | 42 | 123 | $81,303 | $33,950 | 41.8% |
| 90966 | Home dialysis services per month (20 years or older) | Office | 2022 | 52 | 141 | $60,489 | $33,232 | 54.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 245 | 380 | $67,260 | $21,803 | 32.4% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 190 | 369 | $50,184 | $19,828 | 39.5% |
| 90961 | Dialysis services, 2-3 physician visits per month (20 years or older) | Office | 2022 | 23 | 39 | $16,731 | $8,674 | 51.8% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 73 | 76 | $22,420 | $7,766 | 34.6% |
| 90935 | Hemodialysis procedure with physician evaluation | Facility | 2022 | 89 | 130 | $19,760 | $7,189 | 36.4% |
| 90945 | Dialysis procedure including 1 evaluation | Facility | 2022 | 36 | 86 | $39,474 | $5,589 | 14.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 37 | 37 | $9,028 | $4,029 | 44.6% |
| 90970 | Dialysis services, per day, less than full month service (20 years or older) | Office | 2022 | 15 | 427 | $6,192 | $3,091 | 49.9% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 26 | 31 | $5,890 | $2,404 | 40.8% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 11 | 13 | $3,575 | $1,102 | 30.8% |
About Dr. Blake Shusterman, MD
Dr. Blake Shusterman, MD is a Nephrology healthcare provider based in Greenville, South Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/04/2007. The National Provider Identifier (NPI) number assigned to this provider is 1831301779.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Blake Shusterman, MD has received a total of $66,159 in payments from pharmaceutical and medical device companies, with $61,418 received in 2024. These payments were reported across 231 transactions from 31 companies. The most common payment nature is "Consulting Fee" ($61,377).
As a Medicare-enrolled provider, Shusterman has provided services to 4,229 Medicare beneficiaries, totaling 8,737 services with total Medicare billing of $606,936. Data is available for 4 years (2020–2023), covering 66 distinct procedure/service records.
Ad
Practice Information
- Specialty Nephrology
- Location Greenville, SC
- Active Since 05/04/2007
- Last Updated 06/17/2011
- Taxonomy Code 207RN0300X
- Entity Type Individual
- NPI Number 1831301779
Products in Payments
- FARXIGA (Drug) $60,236
- JYNARQUE (Drug) $541.44
- Veltassa (Drug) $511.51
- KRYSTEXXA (Biological) $462.21
- NXSTAGE SYSTEM ONE (Device) $242.03
- Auryxia (Drug) $236.30
- Kerendia (Drug) $190.82
- LOKELMA (Drug) $150.63
- ACTHAR (Biological) $123.45
- Rayaldee (Drug) $118.86
- Fabhalta (Drug) $112.81
- SAMSCA (Drug) $111.31
- RAYALDEE (Drug) $104.73
- Renal - PD (Device) $93.75
- Parsabiv (Biological) $90.76
- NORTHERA (Drug) $87.53
- Parsabiv (Drug) $83.25
- ENTRESTO (Drug) $82.83
- OPTIFLUX (Device) $80.29
- Tavneos (Drug) $80.17
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Nephrology Doctors in Greenville
William Kendrick, M.d, M.D
Nephrology — Payments: $203,057
Nephrology $203,057
Dr. Barry Gorlitsky, Md, MD
Nephrology — Payments: $175,603
Nephrology $175,603
Richard Blair, M.d, M.D
Nephrology — Payments: $13,340
Nephrology $13,340
Anthony Provenzano
Nephrology — Payments: $10,873
Nephrology $10,873
Dr. Amita Patel, M.d, M.D
Nephrology — Payments: $9,091
Nephrology $9,091
Dr. Wilson Parry, Md, MD
Nephrology — Payments: $7,778
Nephrology $7,778